Home

Sharon Mates

CIK 1585699 · Chairman and CEO · last filed 2026-05-04

Sharon Mates is a Chairman and CEO who has filed 76 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for SPTX, was dated May 4, 2026. Across all open-market trades the lifetime net is −$83.6M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

76

Lifetime Open-Market Net

-$83.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPTX Director — $19.90 — $0 1 2026-05-04
BNTC Director — $11.89 — $0 3 2026-01-26
Intra-Cellular Therapies, Inc. (ITCI) Delisted Chairman and CEO 0 $131.87 $0 -$83.58M 55 2025-04-02

Recent Filings

76 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-04 SPTX Grant (A) — $0 EDGAR
2026-01-26 BNTC Grant (A) — $0 EDGAR
2025-12-03 BNTC Grant (A) — $0 EDGAR
2025-11-07 BNTC Grant (A) — $0 EDGAR
2025-04-02 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed −1,135,235 -$149.85M EDGAR
2025-03-31 Intra-Cellular Therapies, Inc. (ITCI) Delisted Gift (G) — $0 EDGAR
2025-03-10 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed +31,301 -$3.93M EDGAR
2025-03-04 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed +17,991 -$2.18M EDGAR
2025-02-04 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed +15,614 -$1.93M EDGAR
2024-12-06 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed — -$7.42M EDGAR
Showing 1–10 of 76
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.